These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2362454)

  • 1. Influence of progestins on serum hormone levels in postmenopausal women with advanced breast cancer--I. General findings.
    Lundgren S; Lønning PE; Utaaker E; Aakvaag A; Kvinnsland S
    J Steroid Biochem; 1990 Jun; 36(1-2):99-104. PubMed ID: 2362454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of progestins on serum hormone levels in postmenopausal women with advanced breast cancer--II. A differential effect of megestrol acetate and medroxyprogesterone acetate on serum estrone sulfate and sex hormone binding globulin.
    Lundgren S; Lønning PE
    J Steroid Biochem; 1990 Jun; 36(1-2):105-9. PubMed ID: 2141886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profound suppression of plasma estrogens by megestrol acetate in postmenopausal breast cancer patients.
    Lundgren S; Helle SI; Lonning PE
    Clin Cancer Res; 1996 Sep; 2(9):1515-21. PubMed ID: 9816328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of aminoglutethimide on the metabolism of medroxyprogesterone acetate and megestrol acetate in postmenopausal patients with advanced breast cancer.
    Lundgren S; Lønning PE; Aakvaag A; Kvinnsland S
    Cancer Chemother Pharmacol; 1990; 27(2):101-5. PubMed ID: 2249324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the role of intestinal bacteria in metabolism of synthetic and natural steroid hormones.
    Adlercreutz H; Pulkkinen MO; Hämäläinen EK; Korpela JT
    J Steroid Biochem; 1984 Jan; 20(1):217-29. PubMed ID: 6231418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adrenal steroids as parameters of the bioavailability of MA and MPA.
    Willemse PH; Dikkeschei LD; Tjabbes T; van Veelen H; Sleijfer DT
    Eur J Cancer; 1990 Mar; 26(3):359-62. PubMed ID: 2141494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with high-dose estrogen (diethylstilbestrol) significantly decreases plasma estrogen and androgen levels but does not influence in vivo aromatization in postmenopausal breast cancer patients.
    Geisler J; Haynes B; Anker G; Helle H; Ekse D; Dowsett M; Lønning PE
    J Steroid Biochem Mol Biol; 2005 Sep; 96(5):415-22. PubMed ID: 16168635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progestins in breast cancer treatment. A review.
    Lundgren S
    Acta Oncol; 1992; 31(7):709-22. PubMed ID: 1476750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral high-dose progestins as treatment for advanced breast cancer.
    Lundgren S; Kvinnsland S; Utaaker E
    Acta Oncol; 1989; 28(6):811-6. PubMed ID: 2532917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of low and high dose medroxyprogesterone acetate on sex steroids and sex hormone binding globulin in postmenopausal breast cancer patients.
    Dowsett M; Lal A; Smith IE; Jeffcoate SL
    Br J Cancer; 1987 Mar; 55(3):311-3. PubMed ID: 2952154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum concentrations of estrogens, sex hormone-binding globulin, and androgens and risk of breast cancer in postmenopausal women.
    Adly L; Hill D; Sherman ME; Sturgeon SR; Fears T; Mies C; Ziegler RG; Hoover RN; Schairer C
    Int J Cancer; 2006 Nov; 119(10):2402-7. PubMed ID: 16894564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocrine effects of medroxyprogesterone acetate: relation between plasma levels and suppression of adrenal steroids in patients with breast cancer.
    van Veelen H; Willemse PH; Sleijfer DT; Sluiter WJ; Doorenbos H
    Cancer Treat Rep; 1985 Sep; 69(9):977-83. PubMed ID: 3161613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in serum sex steroid levels during megestrol acetate therapy.
    Pommier RF; Woltering EA; Fletcher WS
    Surg Oncol; 1994 Dec; 3(6):351-9. PubMed ID: 7773452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of progestins on receptor levels in breast cancer metastasis.
    Lundgren S; Kvinnsland S; Varhaug JE; Utaaker E
    Anticancer Res; 1987; 7(1):119-23. PubMed ID: 3032071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma levels of medroxyprogesterone acetate (MPA), sex-hormone binding globulin, gonadal steroids, gonadotrophins and prolactin in women during long-term use of depo-MPA (Depo-Provera) as a contraceptive agent.
    Jeppsson S; Gershagen S; Johansson ED; Rannevik G
    Acta Endocrinol (Copenh); 1982 Mar; 99(3):339-43. PubMed ID: 6461995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
    Stomati M; Monteleone P; Casarosa E; Quirici B; Puccetti S; Bernardi F; Genazzani AD; Rovati L; Luisi M; Genazzani AR
    Gynecol Endocrinol; 2000 Oct; 14(5):342-63. PubMed ID: 11109974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized comparison of megestrol acetate (MA) and medroxyprogesterone acetate (MPA) in patients with advanced breast cancer.
    Willemse PH; van der Ploeg E; Sleijfer DT; Tjabbes T; van Veelen H
    Eur J Cancer; 1990 Mar; 26(3):337-43. PubMed ID: 2141491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum concentrations of estrogens, sex hormone binding globulin, and androgens and risk of breast hyperplasia in postmenopausal women.
    Schairer C; Hill D; Sturgeon SR; Fears T; Mies C; Ziegler RG; Hoover RN; Sherman ME
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1660-5. PubMed ID: 16030098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variability of serum estrogens among postmenopausal women treated with the same transdermal estrogen therapy and the effect on androgens and sex hormone binding globulin.
    Kraemer GR; Kraemer RR; Ogden BW; Kilpatrick RE; Gimpel TL; Castracane VD
    Fertil Steril; 2003 Mar; 79(3):534-42. PubMed ID: 12620436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of metastatic breast cancer patients with different dosages of megestrol acetate; dose relations, metabolic and endocrine effects.
    Alexieva-Figusch J; Blankenstein MA; Hop WC; Klijn JG; Lamberts SW; de Jong FH; Docter R; Adlercreutz H; van Gilse HA
    Eur J Cancer Clin Oncol; 1984 Jan; 20(1):33-40. PubMed ID: 6363095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.